Clifford Swan Investment Counsel’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Clifford Swan Investment Counsel’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,521	Closed	-$206K	–	320
2019 Q2	$206K	Buy	+3,521	New	+$182K	0.01%	304
2018 Q4	–	Sell	-8,915	Closed	-$410K	–	318
2018 Q3	$410K	Hold	8,915	–	–	0.02%	224
2018 Q2	$389K	Buy	+8,915	New	+$383K	0.02%	229
2017 Q2	–	Sell	-2,863	Closed	-$42K	–	327
2017 Q1	$42K	Hold	2,863	–	–	﹤0.01%	296
2016 Q4	$41K	Buy	2,863 +500	+21%	+$7.74K	﹤0.01%	279
2016 Q3	$41K	Hold	2,363	–	–	﹤0.01%	278
2016 Q2	$40K	Buy	+2,363	New	+$42.2K	﹤0.01%	259

Other funds holding ARNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Clifford Swan Investment Counsel's ARNA Position: Q3 2019 in Review

Clifford Swan Investment Counsel sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2019, closing a stake of 3,521 shares — an estimated $206K sold.

Clifford Swan Investment Counsel first reported a position in ARNA in Q2 2016 and held it in 7 quarters. The position peaked at $410K in Q3 2018. 230 funds tracked by Wall St. Rank hold ARNA as of Q3 2019.

Clifford Swan Investment Counsel reported no remaining Arena Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
Clifford Swan Investment Counsel sold 3,521 Arena Pharmaceuticals Inc shares in Q3 2019, an estimated $206K.
Clifford Swan Investment Counsel first reported a position in Arena Pharmaceuticals Inc in Q2 2016 and held it in 7 quarters.
Clifford Swan Investment Counsel's Arena Pharmaceuticals Inc position peaked at $410K in Q3 2018.
230 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2019.

Based on Clifford Swan Investment Counsel's 13F filing for Q3 2019, filed 12 Nov 2019.